Silverback Therapeutics, Inc. announced the appointment of Jonathan Piazza as chief financial officer. He joins Silverback from Goldman Sachs & Co., where he served as a managing director of Healthcare Investment Banking, advising on and executing biopharma and life sciences financing and strategic transactions. Mr. Piazza will be a member of the executive leadership team and will be responsible for finance, corporate strategy, investor relations and corporate communications.